US 8703758
Bicyclic compound
granted A61KA61K31/41A61K31/415
Quick answer
US patent 8703758 (Bicyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Apr 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/41, A61K31/415, A61K31/439, A61K31/4439